Primemd Inc.
PRMD
$0.00
$0.000.00%
OTC PK
| 12/31/2008 | 09/30/2008 | ||||
|---|---|---|---|---|---|
| Revenue | -49.52% | 0.48% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -49.52% | 0.48% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -49.52% | 0.48% | |||
| SG&A Expenses | -10.91% | -8.94% | |||
| Depreciation & Amortization | 0.00% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -10.25% | -9.00% | |||
| Operating Income | -98.67% | 27.88% | |||
| Income Before Tax | -51.16% | 18.48% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -51.16% | 18.48% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -51.16% | 18.48% | |||
| EBIT | -98.67% | 27.88% | |||
| EBITDA | -112.12% | 31.25% | |||
| EPS Basic | -51.79% | 18.84% | |||
| Normalized Basic EPS | -51.43% | 18.60% | |||
| EPS Diluted | -51.79% | 18.84% | |||
| Normalized Diluted EPS | -51.43% | 18.60% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||